Advertisements
Feeds:
Posts
Comments

Search Results for 'CRISPR'

CRISPR on TED Ideas worth spreading – Ellen Jorgensen

Posted in CRISPR/Cas9 & Gene Editing on February 8, 2018| Leave a Comment »


CRISPR on TED Ideas worth spreading – Ellen Jorgensen Reporter: Aviva Lev-Ari, PhD, RN On same webpage see other CRISPR Talk on TED on the right hand side of the webpage   SOURCE Advertisements

Read Full Post »

CRISPR snips a strand of DNA – Visualization of the Process

Posted in CRISPR/Cas9 & Gene Editing on February 4, 2018| Leave a Comment »


CRISPR snips a strand of DNA – Visualization of the Process Reporter: Aviva Lev-Ari, PhD, RN   Watch what it actually looks like when CRISPR snips a strand of DNA Posted Jan 31, 2018 by Devin Coldewey WATCH VIDEO Molecular animations are an essential way to demystify and explain complex biological systems. Through the use of stunning imagery and attention to detail, […]

Read Full Post »

Developments in CRISPR Patent Dispute: EPO Revokes Broad’s CRISPR Patent

Posted in CRISPR/Cas9 & Gene Editing, Disputes and Settlements, Intellectual Property, Intellectual Property, Innovations, Commercialization, Investment in technological breakthrough, Patent Law in Biotech on January 20, 2018| Leave a Comment »


Developments in CRISPR Patent Dispute: EPO Revokes Broad’s CRISPR Patent Curator: Aviva Lev-Ari, PhD, RN     Mixed views on Broad’s fate after EPO revokes CRISPR patent https://www.lifesciencesipreview.com/news/mixed-views-on-broad-s-fate-after-epo-revokes-crispr-patent-2671   EPO Revokes Broad’s CRISPR Patent The Broad Institute of MIT and Harvard University is at risk of losing its dominant position over the intellectual property covering […]

Read Full Post »

CRISPR Based Research Awarded NHGRI Grants, The University of California, Berkeley’s Doudna will receive $2.1 million and The Broad Institute’s Zhang will receive $1.1 million

Posted in CRISPR/Cas9 & Gene Editing on August 25, 2017| Leave a Comment »


CRISPR Based Research Awarded NHGRI Grants, The University of California, Berkeley’s Doudna will receive $2.1 million and The Broad Institute’s Zhang will receive $1.1 million Reporter: Aviva Lev-Ari, PhD, RN   UPDATED on 10/10/2017 Gene Editing Market: CRISPR/CAS9 to be the fastest-growing technology segment – 2024 Request for Sample Copy of this Report @ http://bit.ly/2wExTM9 Rising […]

Read Full Post »

Appellate Brief Seeking Reversal of U.S. Patent Board Decision on CRISPR/Cas9 Gene Editing

Posted in CRISPR/Cas9 & Gene Editing, Disputes and Settlements, Intellectual Property, Intellectual Property, Innovations, Commercialization, Investment in technological breakthrough, Patent Law in Biotech on August 1, 2017| Leave a Comment »


Appellate Brief Seeking Reversal of U.S. Patent Board Decision on CRISPR/Cas9 Gene Editing Reporter: Aviva Lev-Ari, PhD, RN [Boldface added] Appeal seeks reversal of Patent Trial and Appeal Board decision terminating interference without determining priority of inventorship of CRISPR/Cas9 gene editing Brief asserts that the Board failed to properly apply controlling U.S. Supreme Court and […]

Read Full Post »

Innovations on the CRISPR System for Gene Editing: (1) Cryo-electron microscopy-based visualization of Cas3 Enzyme Cleavage (2) New tool testing an entire genome against a CRISPR molecule to predict potential errors and interactions

Posted in CRISPR/Cas9 & Gene Editing, tagged on July 3, 2017| Leave a Comment »


Innovations on the CRISPR System for Gene Editing: (1) Cryo-electron microscopy-based visualization of Cas3 Enzyme Cleavage (2) New tool testing an entire genome against a CRISPR molecule to predict potential errors and interactions Curator and Reporter: Aviva Lev-Ari, PhD, RN   Boom in human gene editing as 20 CRISPR trials gear up A pioneering CRISPR […]

Read Full Post »

Doudna and Charpentier and their teams to receive wide-ranging patents in many countries: European Patent Office (EPO) and UK Intellectual Property Office – broad patent for CRISPR-Cas9 gene-editing technology to the University of California and the University of Vienna

Posted in CRISPR/Cas9 & Gene Editing on April 28, 2017| Leave a Comment »


Doudna and Charpentierand their teams to receive wide-ranging patents in many countries:  European Patent Office (EPO) and UK Intellectual Property Office – broad patent for CRISPR-Cas9 gene-editing technology to the University of California and the University of Vienna Reporter: Aviva Lev-Ari, PhD, RN   The EPO patent will cover the single-guide CRISPR-Cas9 technology in cells of […]

Read Full Post »

Gene Editing Consortium of Biotech Companies: CRISPR Therapeutics $CRSP, Intellia Therapeutics $NTLA, Caribou Biosciences and ERS Genomics, UC, Berkeley (Doudna’s IP) and University of Vienna (Charpentier’s IP), appealing the decision ruled that there was no interference between the two sides, to the U.S. Court of Appeals for the Federal Circuit, targeting patents from The Broad Institute.

Posted in CRISPR/Cas9 & Gene Editing, Disputes and Settlements, Intellectual Property, Intellectual Property, Innovations, Commercialization, Investment in technological breakthrough, International Global Work in Pharmaceutical, Patent Law in Biotech on April 13, 2017| Leave a Comment »


Gene Editing Consortium of Biotech Companies: CRISPR Therapeutics $CRSP, Intellia Therapeutics $NTLA, Caribou Biosciences, ERS Genomics, UC, Berkeley (Doudna’s IP) and University of Vienna (Charpentier’s IP), is appealing the decision ruled that there was no interference between the two sides, to the U.S. Court of Appeals for the Federal Circuit, targeting patents from The Broad Institute. […]

Read Full Post »

CRISPR Patent Battle Determined on 2/15/2017 – USPTO issues a verdict in legal tussle over rights to genome-editing technology

Posted in CRISPR/Cas9 & Gene Editing, Disputes and Settlements, Intellectual Property, Intellectual Property, Innovations, Commercialization, Investment in technological breakthrough, Patent Law in Biotech on February 16, 2017| Leave a Comment »


CRISPR Patent Battle Determined on 2/15/2017 – USPTO issues a verdict in legal tussle over rights to genome-editing technology Curator: Aviva Lev-Ari, PhD, RN Broad Institute prevails in heated dispute over CRISPR patents Sharon Begley sharon.begley@statnews.com @sxbegle In a one-sentence judgment by the Patent Trial and Appeal Board, the three judges decided that there is “no […]

Read Full Post »

Top 50 Women in CRISPR : Women in CRISPR, Legal Status of Inventions and Declaration of the Heroes in CRISPR

Posted in CRISPR/Cas9 & Gene Editing, Women in Life Sciences on January 31, 2017| Leave a Comment »


Top 50 Women in CRISPR : Women in CRISPR, Legal Status of Inventions and Declaration of the Heroes in CRISPR Curator: Aviva Lev-Ari, PhD, RN   Part 1: Top 50 Women in CRISPR : Women in CRISPR  See List, below SOURCE https://docs.google.com/spreadsheets/u/1/d/10sOQkAg_IKkqozJXqdewiGi6-88W1gnfq5D3g-m22Og/htmlview Part 2: UPDATED – Status “Interference — Initial memorandum” – CRISPR/Cas9 – The […]

Read Full Post »

Next »